Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

e0147 Mechanism of different activators of PPARαregulating plasminogen activator inhibitor-1 expression

View through CrossRef
Objective To observe the effects of fenofibrate and linoleic acid which was the different activators of PPARα on the expression of PAI-1 and PPARα in HepG2 cells. To investigate the relationship and mechanisms between the promoter and expression of PAI-1 that how the fenofibrate and linoleic acid to act on PAI-1. And to observe if PPARα involved in this procession. Methods HepG2 cells were exposed to fenofibrate and linoleic acid in varying concentrations, RT-PCR was used to determine the mRNA expression of PAI-1 and PPARα. Several luciferase reporter gene recombinant plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17bp were constructed and transiently transfected into HepG2 cells. At the same time, co-transfected with PPARα-pSG5 expression plasmid, then different stimulating factors were added to induce the transfected cells. Transcriptional activity of PAI-1 was demonstrated by the measure of luciferase activity. Results 1. Fenofibrate could remarkably decreased PAI-1 mRNA expression in HepG2 cells (p<0.05 or p<0.01), but linoleic acid could significant increased PAI-1 mRNA level (p<0.05 or p<0.01), and they were all in a concentration-dependent manner. 2. Fenofibrate and linoleic acid could raise the mRNA level of PPARα (p<0.05 or p<0.01), which were also in a concentration-dependent way. 3. The PAI-1 transcriptional activity were significantly suppressed by fenofibrate (p<0.05), but induced by linoleic acid (p<0.01) in HepG2 cells transfected with PAI-pGL3 total length promoter constructs. 4. When co-transfected with PPARα-pSG5, fenofibrate could suppress the level of PAI-1 transcription further more (p<0.05), while increased y linoleic acid (p<0.01). 5. The PAI-1 transcriptional activity were very inconsistent when transfected with the plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17 bp. Conclusions Fenofibrate and linoleic acid could increase the mRNA level of PPARα, and they regulate the synthesis of PAI-1 from transcriptional level, which was concerned with the activated of PPARα by Fenofibrate and linoleic acid. The sequences that could regulate the expression of PAI-1 gene induced by fenofibrate might exist in the areas from −804 to −636 and −636 to −449 of PAI-1 promoter and existed in the areas rom −804 to −636 and −449 to −276 induced by linoleic acid. The effects on expression of PAI-1 were very inconsistently, so there might be other mechanisms involved.
Title: e0147 Mechanism of different activators of PPARαregulating plasminogen activator inhibitor-1 expression
Description:
Objective To observe the effects of fenofibrate and linoleic acid which was the different activators of PPARα on the expression of PAI-1 and PPARα in HepG2 cells.
To investigate the relationship and mechanisms between the promoter and expression of PAI-1 that how the fenofibrate and linoleic acid to act on PAI-1.
And to observe if PPARα involved in this procession.
Methods HepG2 cells were exposed to fenofibrate and linoleic acid in varying concentrations, RT-PCR was used to determine the mRNA expression of PAI-1 and PPARα.
Several luciferase reporter gene recombinant plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17bp were constructed and transiently transfected into HepG2 cells.
At the same time, co-transfected with PPARα-pSG5 expression plasmid, then different stimulating factors were added to induce the transfected cells.
Transcriptional activity of PAI-1 was demonstrated by the measure of luciferase activity.
Results 1.
Fenofibrate could remarkably decreased PAI-1 mRNA expression in HepG2 cells (p<0.
05 or p<0.
01), but linoleic acid could significant increased PAI-1 mRNA level (p<0.
05 or p<0.
01), and they were all in a concentration-dependent manner.
2.
Fenofibrate and linoleic acid could raise the mRNA level of PPARα (p<0.
05 or p<0.
01), which were also in a concentration-dependent way.
3.
The PAI-1 transcriptional activity were significantly suppressed by fenofibrate (p<0.
05), but induced by linoleic acid (p<0.
01) in HepG2 cells transfected with PAI-pGL3 total length promoter constructs.
4.
When co-transfected with PPARα-pSG5, fenofibrate could suppress the level of PAI-1 transcription further more (p<0.
05), while increased y linoleic acid (p<0.
01).
5.
The PAI-1 transcriptional activity were very inconsistent when transfected with the plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17 bp.
Conclusions Fenofibrate and linoleic acid could increase the mRNA level of PPARα, and they regulate the synthesis of PAI-1 from transcriptional level, which was concerned with the activated of PPARα by Fenofibrate and linoleic acid.
The sequences that could regulate the expression of PAI-1 gene induced by fenofibrate might exist in the areas from −804 to −636 and −636 to −449 of PAI-1 promoter and existed in the areas rom −804 to −636 and −449 to −276 induced by linoleic acid.
The effects on expression of PAI-1 were very inconsistently, so there might be other mechanisms involved.

Related Results

SUMMARY
SUMMARY
SUMMARYThe purpose of the present monograph is to give an account of the distribution of fibrinolytic components in the organism, with special reference to the tissue activator of ...
Comparative metabolism of plasminogen glycoforms I and II in the alloxan-diabetic rabbit
Comparative metabolism of plasminogen glycoforms I and II in the alloxan-diabetic rabbit
The metabolism of plasminogen glycoforms I and II was measured in alloxan-induced diabetic and in age-matched control rabbits. Radiolabeled plasminogen I and II were degraded signi...
Plasminogen interactions with platelets in plasma
Plasminogen interactions with platelets in plasma
In this report we used a fluorescent flow cytometry-based assay to examine plasminogen binding to platelets in plasma. Our data indicate that platelets activated in platelet-rich p...
Plasminogen interactions with platelets in plasma
Plasminogen interactions with platelets in plasma
Abstract In this report we used a fluorescent flow cytometry-based assay to examine plasminogen binding to platelets in plasma. Our data indicate that platelets acti...
Pyruvate Kinase Activators in Sickle Cell Anemia: A Systematic Review and Single-Arm Meta-Analysis
Pyruvate Kinase Activators in Sickle Cell Anemia: A Systematic Review and Single-Arm Meta-Analysis
Introduction Pyruvate kinase (PK) activators, initially developed for patients with pyruvate kinase deficiency, have the potential to increase ATP production and ...
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo
Plasminogen activators urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) are extracellular proteases involved in various tissue remodeling proc...
Further Characterization Of SK-Potentiator Of Plasminogen
Further Characterization Of SK-Potentiator Of Plasminogen
Streptokinase (SK) forms a complex with human plasminogen (plg) or plasmin, and the resulting complex (SK-activator) functions to convert plg to plasmin. We have indicated that hum...
The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease
The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease
AbstractAlthough plasminogen is a key protein in fibrinolysis and several mutations in the plasminogen gene (PLG) have been identified that result in plasminogen deficiency, there ...

Back to Top